{
    "2018-07-30": [
        [
            {
                "time": "",
                "original_text": "巨丰午评：两类股的炒作或结束",
                "features": {
                    "keywords": [
                        "巨丰",
                        "午评",
                        "炒作",
                        "结束"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物周报：建议关注中报表现出短期防御配置低估值流通",
                "features": {
                    "keywords": [
                        "医药生物",
                        "增持评级",
                        "中报",
                        "防御配置",
                        "低估值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：优选中报业绩优异标的 布局估值切换行情",
                "features": {
                    "keywords": [
                        "医药生物",
                        "强于大市评级",
                        "中报",
                        "业绩优异",
                        "估值切换"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药*全铭】8月关注医药股估值切换带来的超额收益机会，推荐我武生物、长春高新等",
                "features": {
                    "keywords": [
                        "医药",
                        "估值切换",
                        "超额收益",
                        "我武生物",
                        "长春高新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}